Orbimed Advisors LLC Morphic Holding, Inc. Transaction History

Orbimed Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$26.12 - $34.07 $1.41 Million - $1.84 Million	54,000 Added 9.67%	612,500 $20.9 Million
Q1 2024 May 15, 2024	BUY	$26.64 - $40.31 $7.6 Million - $11.5 Million	285,100 Added 104.28%	558,500 $19.7 Million
Q4 2023 Feb 14, 2024	BUY	$19.95 - $31.0 $1.29 Million - $2.01 Million	64,900 Added 31.13%	273,400 $7.9 Million
Q2 2023 Aug 14, 2023	BUY	$34.33 - $62.11 $7.16 Million - $12.9 Million	208,500 New	208,500 $12 Million

27.6M

4.2K

200K

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $2.19B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.